and it benefits a single company, turns out to be amgen, maybe a few others, but this is an amgen-inspired plan that's going to cost medicare and taxpayers half a billion dollars. now, i want that money back. but there's a second reason that's even in many ways much more important. congress is not trusted as an institution. and when there is no trust for that institution, and then we take actions like this, where for the benefit of a company that's very powerful and well-connected, we charge taxpayers a half a billion dollars extra, that means that that institutional disrespect increases, and it's going to make much more difficult the challenge we have to essentially make the tough decisions on all kinds of policies. >> you made a tough statement in washington in which you said actually congress is less popular than cockroaches and root canals because of actions like these. >> no, but that's true. i mean, that poll that came out, it actually says it all. people don't trust the institution. and you know what? they're right not to trust it when this kind of thing happens. when there is this

>> amgen. can you get into amgen, sitting right on support. you have this news coming out.ering the bar a little bit. as long as it holds the support sitting on as we speak. get into a quality name on a pullback on the downside. >> joey. >> one of the best names in the industry, strong, strong balance sheet, dividend will continue to flow, share buyback program, deep into 2014. take the weakness and use it as an advantage. >> heard from barbara ryan, onyx, illiad, let's check in what seema is working on for fast at 5:00. >> a lot of movement in biotech. we're also seeing a lot of movement in airline stocks from boeing's mishap yesterday to deutsche bank upgrading southwest airlines and jetblue. that's a hot debate on twitter. what is the best airline stock to own in 2013. get in on the conversation. don't be shy. tweet us at christina fast money. we'll discuss your tweets tonight at 5:00 p.m. eastern. scott. >> seema, we'll look forward to that. the eurozone hitting a milestone, not exactly the kind it wants with new data showing highest unemployment rate on record in novem

. >> doc, what about amgen? what about gilead? >> on the list, i like qwest diagnostics the best. i'm looking to see what happens with biogen, quite frankly. their als treatment they had disappointing results this week that they released. that stock was hit on that news. if that one corrects enough i like that one a lot because of the other multiple sclerosis drugs and the rest they have in their pipeline. so qwest, amgen, biogen, those are my three. >>> up next, our top three trades, plus the one thing that needs to happen to keep the bulls out of the danger zone. >>> and what could happen to the greenback if the fed takes that punch bowl away. we're back from the new york stock exchange in two minutes. c'mon dad! i'm here to unleash my inner cowboy... instead i got heartburn. [ horse neighs ] hold up partner. prilosec isn't for fast relief. try alka-seltzer. kills heartburn fast. yeehaw! >>> we're bearish on gold, bearish on bonds and bullish on stocks. >> that was keith mccullough yesterday. gold is down more than 1% today. almost 2% as a matter of fact. six straight weekly los

and charlene kabcenell foundation -- the vadasz family foundation -- the wyncote foundation -- the amgen foundation and the george g. and jeanette a. stuart charitable trust. support is also provided by the members of kqed.

and charlene kabcenell foundation -- the vadasz family foundation -- the wyncote foundation -- the amgenundation -- and the george g. and jeanette

additional support provided by -- the amgen foundation. the s.d. bechtel, jr. foundation.

the world's largest biotech company, amgen lowered its outlook for earnings.t get a research tax credit it was expecting. nonetheless, amgen is up 88, up a little. next news on the keystone pipeline. an oil industry spokesperson weighs in on whether we might still build it. that's new coming up next. the dow is up 74 points. 13,4 hush 13,400. stuart: drill baby drill, texas has what looks like a huge budget surplus, upwards of 9 billion bucks. thanks to energy production. according to one analysis, the taxable value of oil produced in texas surged to 39 billion in 2011, result, texas led the nation in job gains adding about 700,000 jobs. imagine what keystone would do for the nation's economy if it's not stopped first. which brings us to this, a new study says that oil production at canada's oil sands area has polluted surrounding lakes with chemicals that cause cancer. that's where the proposed keystone pipeline would originate. jack gerard is the president and ceo of the american petroleum institute. he joins us from d.c. jack, i've got to say that once the

apple on tap for tomorrow, trading flat at the moment, and amgen reporting earnings tomorrow.er lightly ahead of that report. and medivation is higher. johnson and johnson showed an increase in sales, and the market is taking this as a bullish signal for medivation to gain share from j & j in the prostate cancer market. >>> bertha bertha coomb is back more on apple. >> apple say they think that samsung has disrupted the situation for apple. android is gaining. nonetheless they think with all of these things, which is helping to attract a strong user base, they don't believe apple is out of the game and headed south. we'll learn tomorrow. they still say apple needs to defend it's growth story. >> bertha, thank you very much. >>> let's check in on the bond market which is getting competition today from stocks. the bond market also waiting to see what some surveys later this week will show us. right now looking at the curve, the ten-year note is yielding 1.83%. the 30-year has stubbornly been above the 3% level. that's what traders are starting to focus on, not starting but have

so i like stocks like amgen, watson pharmaceutical, texas capital bank shares, three different, one megarge, one midcap all doing very well. they underperformed the market last month. >> you also like europe. >> yes. >> you continue to like europe. >> yes. >> you've been very successful where you've placed your bets in europe. looking at hsbc in particular in the financial services arena. why that ver other stocks? >> look, europe had a very good second half of the year. that's coming off a bad 2009. >> the comparisons. >> 2010, 2011. we're only six months into this. european banks will continue to do well. yesterday restrictions to agreements. that will help those stocks. they remain pretty cheap even though they had a nic move. >> put a little risk in your portfolio. >> exactly. >> we'll have you back soon. back to you. >> power rundown. let's get right into it. first up aig paying back $182 billion bailout and launching a thank you america ad campaign. "the new york times" says the insurer may join in a lawsuit against the government claiming the deal was unfair. kayla, it's a gnarly

it's the world's biggest biotech it, better than expected forecast from amgen. again, only just. dow is up. 13,800 is where the dow is right now. up next, a penny worth a million bucks. we have it for you and here is the question, why isn't gold taking off if everybody around the world keeps on printing money as they are? we have an unbiased gold watcher with us next. stay there. (announcer) at scottrade, our clients trade and invest exactly how they want. with scottrade's online banking, i get one view of my bank and brokerage accounts with one login... to easily move my money when i need to. plus, when i call my local scottrade office, i can talk to someone who knows how i trade. because i don't trade like everi'm with scottrade. me. (announcer) scottrade. awarded five-stars from smartmoney magazine. omnipotent of opportunity. you know how to mix business... with business. and you...rent from national. because only national lets you choose any car in the aisle. and go. you can even take a full-size or above. and still pay the mid-size price. i could get used t

sorry you'll have to wake up at 4:00 amgen soon. ouch.theater right there. >> this is one of our viewers in los angeles. the best part of my day was seeing you this morning. to god be the glory. coffee has not tasted this good since september. >> that's a great one. >> that is absolutely true. and imagine that coffee was miracle berries. now, you're talking. >> amazing stuff. thank you, guys. >>> we're going to move on right now. talking about robin, talking about february. it brings us to our countdown to oscar sunday. and it's on, with a look at jennifer lawrence. 22 years young. she just scored a golden globe for her performance in "silver linings playbook." and the oscar star could strike gold next. >> you wrote about me? i'm the girl? >> reporter: jennifer lawrence is definitely the girl. >> jennifer lawrence, "silver linings playbook." >> reporter: her golden globes speech got everyone talking, when she gloated about beating meryl streep. >> but she wasn't insulting her idol at all. >> it says, i beat meryl. >> reporter: the candid